Cover Picture: Design of Original Bioactive Formulations Based on Sugar–Surfactant/Non‐steroidal Anti‐inflammatory Catanionic Self‐Assemblies: A New Way of Dermal Drug Delivery (Chem. Eur. J. 11/2007)

Abstract

An original catanionic assembly based on a sugar‐derived surfactant and a non‐steroidal anti‐inflammatory drug (NSAID) is described by I. Rico‐Lattes et al. in their Full Paper on page 3039 ff. These catanionic vesicles provided a bioactive formulation for the dermal administration of NSAIDs. This original formulation showed very interesting benefits. It improved the anti‐inflammatory activity of the NSAID in vivo and it ensured a slower diffusion of the NSAID through the skin.